Imagen de Portada

بیوتکنولوژی دارویی | اصول و کاربردها

Fuente: Zenodo

Guardado en:

Detalles Bibliográficos
Autor principal:	Qalavand, Mostafa
Formato:	Recurso digital
Lenguaje:	persa
Publicado:	Zenodo 2025
Materias:	Pharmacy Research Biotechnology Economics, Pharmaceutical Chemistry, Pharmaceutical Pharmaceutical Research Pharmaceutical industry
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Global Pharmaceutical Container Market 2025 To 2034
por: Sirsat, Nitin
Publicado: (2025)

Environmentally Safe and Just Pharmacy: A Framework and Action Plan for Operating within the Earth System Boundary for Novel Entities.
por: Boxall, Alistair B A, et al.
Publicado: (2026)

Global Sustainable Pharmaceutical Packaging Market 2025 To 2034
por: Sirsat, Nitin
Publicado: (2025)

Global Blister Packaging Machine Pharmaceutical Market 2025 To 2034
por: Sirsat, Nitin
Publicado: (2025)

Evaluation of Pharmaceutical Services in Public Hospital Pharmacies of Federal District-Brazil
por: Rodrigo Fonseca Lima
Publicado: (2018)

Pharmaceutical care practice in patients with chronic kidney disease
por: Dadier Antonio Arroyo Monterroza
Publicado: (2017)

Novel Pharmaceuticals from Kenyan Marine Cyanobacteria.
por: Dzeha, T.
Publicado: (2004)

Willingness to pay for a pharmacist's dispensing service: a cross-sectional pilot study in the state of Penang, Malaysia
por: Asrul A. SHAFIE
Publicado: (2010)

The Estimand Framework and Causal Inference: Complementary Not Competing Paradigms
por: Thomas Drury, et al.
Publicado: (2025)

Confidence Intervals for Validation of Analytical Procedures Under ICH Q2 ( R2 )
por: Paul Faya, et al.
Publicado: (2025)

Using Propensity Score Weighting to Enhance the Operating Characteristics of Power Prior in Leveraging External Data to Augment a Traditional Clinical Study
por: Heng Li, et al.
Publicado: (2025)

Issue Information
Publicado: (2025)

Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary Endpoints
por: Xiaolong Luo, et al.
Publicado: (2025)

Issue Information
Publicado: (2025)

Applying Bias Correction Methods to Build Hybrid Controls Using Real‐World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis
por: Heather J. Litman, et al.
Publicado: (2025)

Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations
por: Saurabh Mukhopadhyay, et al.
Publicado: (2025)

Adaptive Constrained Weighted Estimation for Incorporating Multiple External Information Sources
por: Keita Takahashi, et al.
Publicado: (2025)

A Weighted Geometric Average Hazard Ratio Based Sample Size Formula for Non‐Proportional Hazards and Its Application to a Smoothed Piecewise Model in Cancer Immunotherapy Trial Design
por: Qingyang Zhang, et al.
Publicado: (2025)

Extending Multiple Testing With Unknown Test Dependency via the CoCo Test: With Applications to Cancer Studies
por: Jiangtao Gou, et al.
Publicado: (2025)

Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective
por: Ping Gao, et al.
Publicado: (2025)

Why “Minimal Clinically Important Difference” for Interpreting the Magnitude of the Treatment Effect Is Not Useful
por: Jitendra Ganju
Publicado: (2025)

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies
por: Chiara Micoli, et al.
Publicado: (2025)

Finding the Optimal Number of Splits and Repetitions in Double Cross‐Fitting Targeted Maximum Likelihood Estimators
por: Mohammad Ehsanul Karim, et al.
Publicado: (2025)

Informing the Borrowing Process for Dose‐Finding Trials by Estimating the Similarity Between Population‐Specific Dose‐Toxicity Curves
por: Dario Zocholl, et al.
Publicado: (2025)

Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study
por: Jerome Sepin, et al.
Publicado: (2025)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
por: Zhiwei Zhang, et al.
Publicado: (2025)

Issue Information
Publicado: (2025)

Average Hazard as Harmonic Mean
por: Yasutaka Chiba
Publicado: (2025)

Prediction Intervals for Overdispersed Binomial Endpoints and Their Application to Toxicological Historical Control Data
por: Max Menssen, et al.
Publicado: (2025)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
por: Anders Granholm, et al.
Publicado: (2025)

CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug‐Combination Trials
por: Tomoyoshi Hatayama, et al.
Publicado: (2025)

Issue Information
Publicado: (2025)

The Wilcoxon–Mann–Whitney Estimand Versus Differences in Medians or Means
por: Linda J. Harrison, et al.
Publicado: (2025)

A Tree‐Based Scan Statistic for Detecting Signals of Drug–Drug Interactions in Spontaneous Reporting Databases
por: Seok‐Jae Heo, et al.
Publicado: (2025)

BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
por: Ryo Kitabayashi, et al.
Publicado: (2025)

Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk–Benefit Analysis
por: Utkarsh Chauhan, et al.
Publicado: (2025)

Mediation Analysis of Path‐Specific Effects in Randomised Clinical Trials With Repeatedly Measured Mediators and Outcomes
por: Martin Linder, et al.
Publicado: (2025)

Statistical Consideration for Event‐Free Survival With Cure Rate in Acute Myeloid Leukemia Studies
por: Yuichiro Kaneko, et al.
Publicado: (2025)

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions
por: Cesar Torres, et al.
Publicado: (2025)

A Commensurate Prior Model With Random Effects for Survival and Competing Risk Outcomes to Accommodate Historical Controls
por: Manoj Khanal, et al.
Publicado: (2025)